Executive Summary
Overnight SEC 8-K filings from January 23, 2026, show a heavy concentration of financial results disclosures from regional banks and select industrials, marking the early stages of Q4 earnings season, alongside clusters of executive changes, M&A announcements in SPACs/small caps, and generic 'other events' with exhibits. All 41 filings exhibit neutral sentiment with pervasive lack of quantitative details, limiting immediate catalysts but highlighting potential volatility in banking and biotech upon exhibit review. Cross-filing patterns suggest stable portfolio positioning with no systemic shocks, but alpha opportunities in parsing bank earnings trends and monitoring undisclosed M&A structures for dilution risks.
Tracking the trend? Catch up on the prior US Pre-Market SEC Filings Roundup digest from January 21, 2026.
Investment Signals(4)
- Regional Banks (FIRST CITIZENS, WEBSTER, BANCFIRST)▲
Cluster of pre-market Q4 earnings releases provides sector visibility ahead of broader season [NEUTRAL-to-BULLISH]
- Booz Allen Hamilton / Earnings↓(BULLISH)▲
High-materiality financial results filing signals potential defense consulting strength amid fiscal year-end
Officer change paired with Reg FD disclosure may indicate strategic tech pivot [NEUTRAL-to-BULLISH]
Multi-item filing on material agreement and equity sales hints at growth funding despite dilution [NEUTRAL-to-BEARISH]
Risk Flags(4)
High materiality (8/10) with all financial metrics NOT_DISCLOSED, risks earnings surprises impacting regional bank peers
Unregistered sales (Item 3.02) alongside material agreement without valuation details flags shareholder dilution
- OneIM Acquisition & Datavault AI / M&A Opacity▼
High-risk merger filings lacking parties, terms, or impacts, potential for deal failures or overvaluation
- Multiple Officer Changes (Ocular Therapeutix, Massimo, Matador)▼
Undisclosed leadership shifts across biotech/energy raise governance instability concerns
Opportunities(4)
- Banking Sector / Earnings Momentum◆
Parse exhibits from FIRST CITIZENS (8/10 materiality), WEBSTER for early read on loan quality, NIM trends vs. Fed policy
- SPAC M&A (ASPAC III, OneIM, ETHZilla)◆
Undisclosed deals in small caps offer alpha if exhibits reveal undervalued targets or synergies
- Biotech Disclosures (NextCure, Lantern Pharma)◆
Reg FD and results filings cluster signals pipeline updates, potential for clinical catalysts
High materiality (8/10) material agreement + earnings combo positions for renewable energy growth narrative
Sector Themes(3)
- Regional Banking Earnings Prelude◆
4+ filings (FIRST CITIZENS, WEBSTER, BANCFIRST, 1ST SOURCE) initiate Q4 season, watch for deposit/credit trends amid rate cut expectations
- Biotech/Health Leadership Flux◆
6+ officer changes and results (Ocular, NextCure, Sanara, Acadia) plus Reg FD suggest pipeline or operational resets, volatility amplifier
- Small-Cap M&A Surge◆
SPAC/merger activity (LanzaTech, ASPAC III, Datavault, ETHZilla) correlates with equity issuances, implying capital raises for consolidation plays
Watch List(4)
Highest materiality earnings filing; monitor exhibits for asset quality metrics influencing KBW bank index
Multi-risk M&A/equity sale details critical for dilution assessment and clean energy sector positioning
Officer change + Reg FD may precede semi guidance, track for chip sector ripple effects
- ASPAC III & OneIM👁
SPAC merger opacity requires exhibit scrutiny for de-SPAC timelines and valuation risks
Filing Analyses(41)
23-01-2026
Diversified Energy Co filed a Form 8-K on January 23, 2026 (AccNo: 0001140361-26-002106, size: 169 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event or exhibits are disclosed in the provided filing summary. Sector not specified.
23-01-2026
Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003295, Size: 216 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). The sector is not specified. No details on the specific events, transactions, financial statements, or exhibits are provided in the filing summary.
23-01-2026
Super League Enterprise, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001437749-26-001802), reporting under Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item general filing with no specific details on the amendments, disclosures, or exhibits provided in the summary. No numerical values, transaction sizes, or strategic impacts are disclosed.
23-01-2026
DAXOR CORP filed a Form 8-K on 2026-01-23 (AccNo: 0001493152-26-003302, Size: 18 MB) under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. All quantitative data including transaction values, share counts, percentages, and financial metrics are NOT_DISCLOSED.
23-01-2026
Corvus Pharmaceuticals, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-005968, Size: 550 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on voluntary disclosure of unspecified other events with attached exhibits. No core event details, quantitative data, named entities, or scheduled events are explicitly stated.
23-01-2026
News Corp filed a Form 8-K on January 23, 2026 (AccNo: 0001564708-26-000016, Size: 400 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.
23-01-2026
1ST SOURCE CORP filed a Form 8-K on January 23, 2026 (AccNo: 0000034782-26-000004, Size: 906 KB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a financial results disclosure for the US market. No specific financial metrics, transaction details, or numerical values are provided in the filing summary.
23-01-2026
Forge Global Holdings, Inc. filed a Form 8-K on January 23, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, likely results from a shareholder meeting. Item 9.01 discloses financial statements and exhibits. No specific vote details, numerical data, or transaction values are provided in the filing summary.
23-01-2026
OneIM Acquisition Corp. filed an 8-K on January 23, 2026 (AccNo: 0001213900-26-006879), announcing a Merger/Acquisition event under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on deal structure, parties involved, valuation, transaction type, strategic rationale, or financial metrics are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
LanzaTech Global, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001628280-26-003163), reporting multiple items including Entry into a Material Definitive Agreement (Item 1.01), Unregistered Sales of Equity Securities (Item 3.02), Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (Item 5.03), and Financial Statements and Exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, or financial impacts disclosed in the provided summary. Sector is not specified.
23-01-2026
SYNTEC OPTICS HOLDINGS, INC. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003285, Size: 275 KB), reporting Item 5.07 (Submission of Matters to a Vote of Security Holders) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing shareholder vote results and attached exhibits. No details on vote outcomes, matters voted on, or exhibit contents are provided in the summary.
23-01-2026
InnSuites Hospitality Trust filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003274, Size: 228 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific events, transactions, financial statements, or exhibits are provided in the filing summary. Sector not specified.
23-01-2026
BancFirst Corp (/OK/) filed an 8-K on January 23, 2026 (AccNo: 0001193125-26-019710, Size: 1 MB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a financial results disclosure with no specific numerical financial metrics, transaction details, or guidance provided in the filing summary. Sector is not specified.
23-01-2026
Petco Health & Wellness Company, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-019795, Size: 171 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific core event, transaction details, financial metrics, or scheduled events disclosed in the provided summary. All quantitative data, named entities, and further details are NOT_DISCLOSED.
23-01-2026
The company filed a Form 8-K on January 23, 2026 (AccNo: 0001803498-26-000003, Size: 158 KB), reporting under Items 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 8.01 (Other Events). This is a multi-item general filing with no specific transaction details, dollar values, share counts, named entities, or scheduled events disclosed. Sector is not specified.
23-01-2026
COLUMBUS MCKINNON CORP filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-020111, Size: 171 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
Materion Corp filed a Form 8-K on January 23, 2026 (AccNo: 0001104657-26-000002, size 177 KB) under Item 2.02 announcing results of operations and financial condition. Sector not specified. No specific financial metrics, transaction details, or scheduled events disclosed in the provided filing summary.
23-01-2026
McEwen Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-005999), reporting unregistered sales of equity securities under Item 3.02. The filing also references Item 9.01 for financial statements and exhibits. No quantitative details, transaction specifics, or additional context are disclosed.
23-01-2026
Booz Allen Hamilton Holding Corp filed a Form 8-K on January 23, 2026 (AccNo: 0001628280-26-003186, Size: 5 MB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results. No specific financial metrics, transaction details, or scheduled events are disclosed in the provided information.
23-01-2026
SilverBox Corp V filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006010), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
SLB LIMITED/NV filed a Form 8-K on January 23, 2026 (AccNo: 0001193125-26-020133), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction values, guidance, or other quantitative details are disclosed in the provided filing summary. Sector is not specified.
23-01-2026
Ocular Therapeutix, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006015, Size: 188 KB) disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, or any named individuals are NOT_DISCLOSED. Sector is not specified.
23-01-2026
Analog Devices Inc filed a Form 8-K on January 23, 2026 (AccNo: 0000006281-26-000008, Size: 220 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation status, reasons, or other quantitative data are provided.
23-01-2026
Axogen, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0000805928-26-000026, Size: 655 KB) reporting Items 1.01 (Entry into a Material Definitive Agreement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the core event, transaction value, financial impacts, or named entities disclosed in the provided summary. All quantitative data, scheduled events, and further context are NOT_DISCLOSED.
23-01-2026
Datavault AI Inc. filed an 8-K on January 23, 2026 (AccNo: 0001104659-26-006014), disclosing under Item 2.01 the completion of an acquisition or disposition of assets, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on parties involved, deal structure, valuation, consideration, or financial metrics are disclosed. Sector is not specified.
23-01-2026
Lantern Pharma Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003314, Size: 16 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing focused on voluntary disclosure of potentially material information and attached exhibits. No core event details, financial metrics, transaction values, or scheduled events are disclosed in the provided filing summary.
23-01-2026
Webster Financial Corp filed an 8-K on January 23, 2026 (AccNo: 0000801337-26-000004), disclosing under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or scheduled events are mentioned.
23-01-2026
Sanara MedTech Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003316, Size: 262 KB) under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). This is a financial results disclosure from the US SEC with sector not specified. No numerical financial metrics, transaction details, named entities beyond the filer, or scheduled events are explicitly stated.
23-01-2026
ETHZilla Corp filed an 8-K on January 23, 2026 (AccNo: 0001213900-26-006924) disclosing under Item 2.01 the completion of an acquisition or disposition of assets. Item 9.01 provides financial statements and exhibits related to the transaction. No details on parties involved, deal structure, valuation, or strategic rationale are specified.
23-01-2026
Massimo Group filed a Form 8-K on 2026-01-23 (AccNo: 0001493152-26-003318, Size: 201 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). No specific details on the affected position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, or any named individuals are provided in the filing summary. Sector is not specified, and no quantitative data, scheduled events, or further governance implications are disclosed.
23-01-2026
NeoVolta Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001683168-26-000482), reporting entry into a material definitive agreement (Item 1.01), results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item mandatory filing for Items 1.01 and 2.02, with voluntary Item 7.01. No specific details on the agreement, transaction values, financial metrics, or impacts are disclosed in the provided information.
23-01-2026
Matador Resources Co filed a Form 8-K on 2026-01-23 (AccNo: 0001628280-26-003190, Size: 205 KB) disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected officer, position, reason, or compensation provided.
23-01-2026
ASPAC III Acquisition Corp. filed a Form 8-K on January 23, 2026 (AccNo: 0001213900-26-006925, Size: 246 KB) under Item 3.02 disclosing unregistered sales of equity securities in connection with a merger/acquisition event. No details on parties involved, deal structure, valuation, consideration, synergies, regulatory pathway, shareholder impact, or sector implications are provided. Sector is not specified.
23-01-2026
NextCure, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006021, Size: 5 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific quantitative data, transaction details, or scheduled events are disclosed in the provided filing summary.
23-01-2026
Tron Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001493152-26-003321), reporting under Item 7.01 Regulation FD Disclosure. No details on the core event, financial impacts, transactions, or scheduled events are explicitly stated in the provided filing summary. Sector not specified.
23-01-2026
Ocugen, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006031), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure with no specific event details, transaction values, or financial metrics provided in the summary. No quantitative data, named entities, or scheduled events are mentioned.
23-01-2026
Webster Financial Corp filed an 8-K on January 23, 2026 (AccNo: 0000801337-26-000006, Size: 1 MB), disclosing under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or other quantitative data are mentioned.
23-01-2026
Bed Bath & Beyond, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001130713-26-000010, Size: 13 MB), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were filed. No specific details on the officer involved, position affected, nature of change (appointment or resignation), reasons, or any quantitative data are disclosed.
23-01-2026
Acadia Healthcare Company, Inc. filed a Form 8-K on 2026-01-23 (AccNo: 0001193125-26-020169, Size: 233 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer position, appointment/resignation status, reasons, or individuals involved are disclosed. Sector not specified.
23-01-2026
Lendway, Inc. filed a Form 8-K on January 23, 2026 (AccNo: 0001104659-26-006044), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, obligation, dollar values, counterparties, or other quantitative data disclosed in the provided summary. Sector is not specified.
Get daily alerts with 4 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 41 filings
🇺🇸 More from United States
View all →March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings